Future Challenges and Opportunities in Online Prescription Drug Promotion Research; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
Center for Communication Science, RTI International, Research Triangle Park, NC, USA
Despite increased availability of online promotional tools for prescription drug marketers, evidence on online prescription drug promotion is far from settled or conclusive. We highlight ways in which online prescription drug promotion is similar to conventional broadcast and print advertising and ways in which it differs. We also highlight five key areas for future research: branded drug website influence on consumer knowledge and behavior, interactive features on branded drug websites, mobile viewing of branded websites and mobile advertisements, online promotion and non-US audiences, and social media and medication decisions.
Hesse BW, Moser RP, Rutten LJ. Surveys of physicians and electronic health information. N Engl J Med. 2010;362(9):859-860.
Liang BA, Mackey TK. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res. 2011;13(3):e64. doi:10.2196/jmir.1775
Tyrawski J, DeAndrea DC. Pharmaceutical companies and their drugs on social media: A content analysis of drug information on popular social media sites. J Med Internet Res. 2015;17(6):e130. doi:10.2196/jmir.4357
Macias W, Lewis LS. A content analysis of direct-to-consumer (DTC) prescription drug Web sites. J Advert. 2003;32(4):43-56.
Levy M, Matiesanu E, Mitskaviets I, Riley M, Daniels D. Prescription drug advertising: Benchmarking and identifying strategies to increase consumers’ engagement with online ads. Report No. HTH06-C04. New York: Jupiter Research; 2006.
Macias W, Lewis LS, Smith TL. Health-related message boards/chat rooms on the web: Discussion content and implications for pharmaceutical sponsorships. J Health Commun. 2005;10(3):209-223.
Davis JJ, Cross E, Crowley J. Pharmaceutical websites and the communication of risk information. J Health Commun. 2007;12(1):29-39.
Huh J, Cude BJ. Is the information “fair and balanced” in direct-to-consumer prescription drug websites? J Health Commun. 2004;9(6):529-540.
Ledford CJ. Content analysis of Internet marketing strategies: How pharmaceutical companies communicate about contraceptives with consumers online. Soc Mar Q. 2009;26(Suppl 1):55-71.
Vigilante WJ, Wogalter MS. Assessing risk and benefit communication in direct-to-consumer medication website advertising. Drug Inf J. 2005;39:3-12.
Chan FW, Wong FY, So WY, Kung K, Wong CK. How much do elders with chronic conditions know about their medications? BMC Geriatr. 2013;13:59. doi:10.1186/1471-2318-13-59
Davis TC, Wolf MS, Bass PF 3rd, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887-894.
Davis TC, Wolf MS, Bass PF, et al. Lower literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21(8):847-851.
Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: An illustration using an antidepressant medication. Ann Pharmacother. 2011;45(4):452-458. doi:10.1345/aph.1P477
Sundar RP, Becker MW, Bello NM, Bix L. Quantifying age-related differences in information processing behaviors when viewing prescription drug labels. PLoS One 2012;7(6):e38819. doi:10.1371/journal.pone.0038819
Wolf MS, Davis TC, Shrank W, et al. To err is human: Patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67(3):293-300.
Huh J, Shin W. Consumer responses to pharmaceutical-company-sponsored disease information websites and DTC branded websites. International Journal of Pharmaceutical and Healthcare Marketing. 2015;9(4):306-329.
Kang H, An S. How direct-to-consumer drug websites convey disease information: Analysis of stigma-reducing components. J Health Commun. 2013;18(12):1477-1491.
Eysenbach G, Powell J, Englesakis M, Rizo C, Stern A. Health related virtual communities and electronic support groups: Systematic review of the effects of online peer to peer interactions. BMJ. 2004;328(7449):1166.